These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 33039794

  • 21. Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma.
    Liang L, Williams MD, Bell D.
    Head Neck Pathol; 2019 Dec; 13(4):529-534. PubMed ID: 30390196
    [Abstract] [Full Text] [Related]

  • 22. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.
    Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG.
    Clin Cancer Res; 2016 Sep 15; 22(18):4623-33. PubMed ID: 27103403
    [Abstract] [Full Text] [Related]

  • 23. Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.
    Jalaly JB, Sanati S, Chernock RD, Dibe DG, El-Mofty SK.
    Head Neck Pathol; 2018 Dec 15; 12(4):488-492. PubMed ID: 29302899
    [Abstract] [Full Text] [Related]

  • 24. Prognostic factors and outcome analysis of salivary duct carcinoma.
    Han MW, Roh JL, Choi SH, Nam SY, Lee HJ, Cho KJ, Lee SW, Kim SY.
    Auris Nasus Larynx; 2015 Dec 15; 42(6):472-7. PubMed ID: 26028371
    [Abstract] [Full Text] [Related]

  • 25. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
    Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE.
    Am J Surg Pathol; 2004 Mar 15; 28(3):319-26. PubMed ID: 15104294
    [Abstract] [Full Text] [Related]

  • 26. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim S.
    JAMA Otolaryngol Head Neck Surg; 2016 May 01; 142(5):489-95. PubMed ID: 26939990
    [Abstract] [Full Text] [Related]

  • 27. Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
    van Boxtel W, Verhaegh GW, van Engen-van Grunsven IA, van Strijp D, Kroeze LI, Ligtenberg MJ, van Zon HB, Hendriksen Y, Keizer D, van de Stolpe A, Schalken JA, van Herpen CM.
    Int J Cancer; 2020 Jun 01; 146(11):3196-3206. PubMed ID: 31745978
    [Abstract] [Full Text] [Related]

  • 28. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
    Masubuchi T, Tada Y, Maruya S, Osamura Y, Kamata SE, Miura K, Fushimi C, Takahashi H, Kawakita D, Kishimoto S, Nagao T.
    Int J Clin Oncol; 2015 Feb 01; 20(1):35-44. PubMed ID: 24553861
    [Abstract] [Full Text] [Related]

  • 29. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
    Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He WL, Xu JB, Zan WH.
    J Surg Oncol; 2012 Sep 01; 106(3):304-10. PubMed ID: 22231933
    [Abstract] [Full Text] [Related]

  • 30. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
    Spachmann PJ, Breyer J, Kalogirou C, Lausenmeyer EM, Weber F, Prohaska S, Denzinger S, Burger M, Kübler H, Otto W, Vergho D.
    Urol Int; 2019 Sep 01; 102(4):413-420. PubMed ID: 30844790
    [Abstract] [Full Text] [Related]

  • 31. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas.
    Yang RK, Zhao P, Lu C, Luo J, Hu R.
    Hum Pathol; 2019 Feb 01; 84():173-182. PubMed ID: 30267779
    [Abstract] [Full Text] [Related]

  • 32. Prognostic value of lymph node density in high-grade salivary gland cancers.
    Hong HR, Roh JL, Cho KJ, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2015 May 01; 111(6):784-9. PubMed ID: 25640975
    [Abstract] [Full Text] [Related]

  • 33. Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.
    Ach T, Zeitler K, Schwarz-Furlan S, Baader K, Agaimy A, Rohrmeier C, Zenk J, Gosau M, Reichert TE, Brockhoff G, Ettl T.
    Virchows Arch; 2013 Jan 01; 462(1):65-72. PubMed ID: 23242174
    [Abstract] [Full Text] [Related]

  • 34. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL, Hsu CS, Liu WM, Lee YC, Lee YC, Chen CL.
    Int J Clin Exp Pathol; 2015 Jan 01; 8(5):5642-9. PubMed ID: 26191276
    [Abstract] [Full Text] [Related]

  • 35. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
    Nakopoulou L, Gakiopoulou H, Keramopoulos A, Giannopoulou I, Athanassiadou P, Mavrommatis J, Davaris PS.
    Histopathology; 2000 Apr 01; 36(4):313-25. PubMed ID: 10759945
    [Abstract] [Full Text] [Related]

  • 36. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
    Di Palma S, Simpson RH, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS.
    Histopathology; 2012 Oct 01; 61(4):629-43. PubMed ID: 22882517
    [Abstract] [Full Text] [Related]

  • 37. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE.
    Cancer; 2016 Oct 15; 122(20):3136-3144. PubMed ID: 27379604
    [Abstract] [Full Text] [Related]

  • 38. Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.
    Karray-Chouayekh S, Trifa F, Khabir A, Sellami-Boudawara T, Frikha M, Gargouri A, Mokdad-Gargouri R.
    Histol Histopathol; 2012 Mar 15; 27(3):377-85. PubMed ID: 22237715
    [Abstract] [Full Text] [Related]

  • 39. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
    Skálová A, Stárek, Kucerová V, Szépe P, Plank L.
    Pathol Res Pract; 2001 Mar 15; 197(9):621-6. PubMed ID: 11569926
    [Abstract] [Full Text] [Related]

  • 40. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
    Šteiner P, Andreasen S, Grossmann P, Hauer L, Vaněček T, Miesbauerová M, Santana T, Kiss K, Slouka D, Skálová A.
    Virchows Arch; 2018 Oct 15; 473(4):471-480. PubMed ID: 29619555
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.